image class="left" url="http://media5.picsearch.com/is?OfY-KSVyXHMdQavDvECqS-DpyIkqm0_l71lyRnQAE5Y&height=191"Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical firms, including the makers of Xarelto, possess a duty to make sure that their drugs are reasonably secure for use - and failure to do so might be grounds for compensation. Our lawyers are working difficult to acquire those hurt by the drug the compensation they are entitled to.













Even though bleeding is really a common complication associated with anticoagulants, it has been alleged that Xarelto is a lot more hazardous than traditional blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This means that, in the event of an emergency, individuals could be at risk for irreversible bleeding difficulties, including life-threatening internal and gastrointestinal hemorrhaging.













In the event you or perhaps a loved 1 suffered a critical bleeding event right after taking Xarelto, you may have legal recourse. For far more data, speak to us today to possess your case reviewed, free of charge of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future medical bills, lost wages, pain and suffering and, in situations of death, funeral expenditures. Additionally, they may be in search of punitive damages, which are normally awarded to punish the defendant and deter other organizations from acting similarly.






Why Are Lawsuits Getting Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs in the lawsuits allege significant and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a secure anticoagulant option.






Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.






Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.













Visit this page for a lot more info on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the one-time offer group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki